AzTrials
AzTrials

Ovarian EndometriomaNCT03585309

The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cysts.

A study testing The impact of electrocoagulation on ovarian reserve after laparoscopic excision of ovarian cysts: in people with Ovarian Endometrioma and Ovary Cyst, run by Ain Shams University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the study is to evaluate the effect of bipolar electrocoagulation on ovarian reserve. Read more about this study

Who is it for?
Ages 20 to 35 years, women only
Conditions the study is for
Ovarian Endometrioma, Ovary Cyst
What is being tested?
The impact of electrocoagulation on ovarian reserve after laparoscopic excision of ovarian cysts:
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
96 participants
Where
1 siteEgypt
Study dates
15 Jul 2018to 31 Jan 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 35 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age: 20-35 years.
  • Uni-bilateral ovarian cyst(s) size without clinical and sonographic suspicion of ovarian cancer.
  • Regular menstrual cycles defined as a cycle length between 25 and 35 days in the 6 months before surgery.
  • Agreement to be enrolled in the study.
  • Endometriosi.
  • Renal disesase.
  • Liver disease.

Who cannot join

  • 1- Prior ovarian surgery 2- Surgical necessity to perform adnexectomy 3- Known endocrine disease 4- Postoperative pathologic diagnosis that was not benign ovarian cyst 5- Oral contraceptive use before surgery last two months. 6-Addison disease. 7.Thyroid disease.

Trial locations and contacts

1 site in 1 country.

Ahmed Nagib, MD contact

+201001403138

Kareem Labib, MD contact

+201005115380

kareem_labib@yahoo.com

Egypt1 site
  • Ain Shams University Maternity Hospital

    Cairo, 1156

    ahmed Nagib, MD, 00201001403138

    Kareem Labib, MD, 00201005115380, kareem_labib@yahoo.com

Other trials in Egypt

About this study

Official title: The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cysts: Randomization Clinical Trial

The aim of the study is to evaluate the effect of bipolar electrocoagulation on ovarian reserve.

Read the detailed description

Laparoscopic ovarian cystectomy is currently considered the treatment of choice in women with benign ovarian cysts and has gained increasing acceptance among gynecologic sur¬geons . However, the safety of this technique in terms of ovarian damage to the operated gonad has recently been questioned. A great deal of evidence supports that the re¬moval of ovarian cysts is associated with injury to the ovarian reserve . Many of these studies involved patients who required assisted reproduction, and they found that the number both of follicles and retrieved oocytes obtained in the operated gonad during ovarian hyperstimulation was markedly reduced when compared with the contralateral intact ovary. However, most of these studies applied ovarian response to gonadotropin hyperstimulation to measure the ovarian reserve. It has been argued that these patients are not representative of all patients undergoing laparoscopic ovarian cystectomy in terms of ovarian damage because these data were acquired from aggressive gonadotropin stimulation which is thought to be different from a natural menstrual cycle .

On the other hand, because ovarian reserve cannot be mea¬sured directly, the evaluation of ovarian reserve is difficult to carry out. The induction of ovarian hyperstimulation in an un¬selected population of surgical patients for the purpose of evaluating ovarian reserve is obviously ethically untenable. The serum level of follicle-stimulating hormone (FSH) is a predictor of functional ovarian reserve , but its usefulness is limited considering that the vast majority of patients un¬dergo monolateral excision of a cyst and the contralateral in¬tact gonad may completely substitute for reduced function of the operated ovary . Given the well-established role of ul¬trasound scanning in the diagnosis and follow-up of ovarian cysts, reported that basal antral follicle number and mean ovarian diameter could be used as indicators of ovarian reserve. found that the value of ovarian stromal blood flow velocity was an initial marker of ovarian reserve before the change of FSH level and ovarian volume.

With the combined use of serum hormonal evaluation and ultrasound examination, the investigators prospectively investigated the ovarian reserve of patients after the excision of benign ovarian cysts. The damage to ovarian reserve was evaluated during through a 12-month follow-up period after the application of bipolar, ultrasonic scalpel electrocoagulation or suture for ovarian cystectomy .

Being tested
The impact of electrocoagulation on ovarian reserve after laparoscopic excision of ovarian cysts:
Medical subject headings
Endometriosis, Ovarian Cysts

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The impact of electrocoagulation on ovarian reserve after laparoscopic excision of ovarian cysts:Procedure or surgery

    Randomization Randomization will be conducted using computer generated table. Group A (48 CASES) without coagulation

    Group A 6 89 92 35 1 15 21 16 60 49 53 91 34 5 94 64 88 58 7 33 8 75 29 56 10 23 37 19 32 71 55 84 36 77 50 2 46 70 82 9 51 54 72 18 25 31 14 63

    Group B (48 CASES) with coagulation Group B 79 38 93 43 52 44 62 47 68 76 86 95 81 83 42 80 94 30 78 61 12 17 66 13 41 59 22 73 39 65 4 90 28 26 3 87 40 85 69 48 27 24 74 57 11 20 67 45

    Allocation and concealment Nineteen six opaque envelopes will be numbered serially and in each envelope the corresponding letter which denotes the allocated group will be put according to randomization table then all envelopes will be closed and put in one box. When the first patient arrives the first envelope will be opened and the patient will be allocated according to the letter inside.

Study groups in NCT03585309
Study groupRoleWhat they receive
Laparascopy comper with coagulation and without coagulationExperimentalNot described
Receives: Procedure: The impact of electrocoagulation on ovarian reserve after laparoscopic excision of ovarian cysts:

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants (Females) with ovarian cyst or dermid cyst or endometrial

    Laparascopy without coagulation excision of ovarian cysts and effect of ovarian reserve RESULIT The result of the study is to evaluate the effect of bipolar electrocoagulation on ovarian reserve.

    Measured: 3 months after surgery

Secondary outcomes (1)
  1. Number of participants (Females) with ovarian cyst or dermid cyst or endometrial

    Laparascopy with coagulation excision of ovarian cysts and effect of ovarian reserve RESULT The result of the study is to evaluate the effect of bipolar electrocoagulation on ovarian reserve.

    Measured: 3 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2018
  2. Study start15 Jul 2018 (estimated)
  3. Primary completion31 Dec 2018 (estimated)
  4. Study completion31 Jan 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Intervention model
Sequential
Masking
None (open label)
Enrolment
96 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03585309
Sponsor's protocol ID
Ain shamsMH
Status last verified
Jul 2018
First submitted
7 May 2018
Last updated
13 Jul 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Asgari Z, Rouholamin S, Hosseini R, Sepidarkish M, Hafizi L, Javaheri A. Comparing ovarian reserve after laparoscopic excision of endometriotic cysts and hemostasis achieved either by bipolar coagulation or suturing: a randomized clinical trial. Arch Gynecol Obstet. 2016 May;293(5):1015-22. doi: 10.1007/s00404-015-3918-4. Epub 2015 Oct 22.

    PubMed 26493551

Questions about this trial

What is this clinical trial studying?

A study testing The impact of electrocoagulation on ovarian reserve after laparoscopic excision of ovarian cysts: in people with Ovarian Endometrioma and Ovary Cyst, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahmed Nagib, MD (+201001403138), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants (Females) with ovarian cyst or dermid cyst or endometrial (time frame: 3 months after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03585309, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in